AnalystsRichard LawRichard Law's Stock Forecasts
AnalystsRichard Law
Sectors:
Industries:
Analyst Ranking
Top 23%
#1122 out of 4870 analysts
Average Return
+4.86%
Win Rate
38%11 out of 29
Risk vs Reward
Poor
Good
Richard Law's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Olema Pharmaceuticals IncOLMA | +234.19% | $3.89 | $13.00 | 2023-03-09 - 2024-03-08 | Buy |
Olema Pharmaceuticals IncOLMA | +204.17% | $4.56 | $13.87 | 2023-02-21 - 2024-02-21 | Buy |
Arvinas IncARVN | +46.97% | $31.98 | $47.00 | 2023-02-23 - 2024-02-23 | Buy |
Mineralys Therapeutics IncMLYS | +46.67% | $10.20 | $14.96 | 2025-02-12 - 2025-05-01 | Strong Buy |
Arvinas IncARVN | +39.16% | $24.67 | $34.33 | 2023-05-07 - 2024-05-07 | Buy |
Richard Law Analyst Color
Get additional color on Richard Law's coverage of popular stocks
Richard Law's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | 1 | Hold | $30.00 | +4.84% | Initiates Coverage On | 24 days ago |
Silence Therapeutics PLCSLN | 2 | Strong Sell | $4.00 | -0.25% | Maintains | 2 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Hold | $15.00 | +90.84% | Maintains | 2 months ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $36.00 | +73.83% | Maintains | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Buy | $73.00 | +76.16% | Maintains | 2 months ago |
Mineralys Therapeutics IncMLYS | 6 | Strong Buy | $24.00 | +60.43% | Maintains | 3 months ago |
Merus NvMRUS | 1 | Strong Buy | $73.00 | +60.62% | Initiates Coverage On | 5 months ago |
Viridian Therapeutics IncVRDN | 2 | Strong Buy | $31.00 | +125.62% | Maintains | 8 months ago |
Olema Pharmaceuticals IncOLMA | 4 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Monte Rosa Therapeutics IncGLUE | 4 | Hold | $11.00 | N/A | Reiterates | 2 years ago |
Verve Therapeutics IncVERV | 2 | Hold | $31.00 | N/A | Reiterates | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Hold | $47.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 6 | Hold | $63.00 | N/A | Maintains | 2 years ago |
Kymera Therapeutics IncKYMR | 8 | Hold | $37.00 | N/A | Maintains | 2 years ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $76.00 | N/A | Reiterates | 2 years ago |
Q32 Bio IncQTTB | 4 | Hold | $36.00 | N/A | Reiterates | 2 years ago |
Editas Medicine IncEDIT | 3 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Arvinas IncARVN | 4 | Buy | $61.00 | N/A | Reiterates | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.